Review of health regulator proposals launched
A scrutiny sub-panel has been formed to consider the proposal that Jersey Care Commission becomes the independent regulator of these services on the island.
The States Assembly said the panel would hold public hearings with key stakeholders as well as invite feedback from private sector service providers who would fall under the remit of the new regulations.
The sub-panel chair Deputy Tom Coles said it was "an extremely important piece of legislation because it aims to protect every islander who uses our key health services".
More news stories for Jersey
Listen to the latest news for Jersey
Formed as a sub-panel of the Environment, Housing and Infrastructure scrutiny panel, the chair is Deputy Tom Coles, the vice chair is Deputy Karen Wilson and the panel members are Deputy Helen Miles and Deputy Jonathan Renouf.
Scrutiny panels work on behalf of the States Assembly and examine the work of the Government, holding ministers to account for their decisions and actions.
Follow BBC Jersey on X and Facebook. Send your story ideas to channel.islands@bbc.co.uk.
Panel to discuss role of regulation in Jersey
Watchdog looks to expand remit to include hospital
Related internet links
Jersey Care Commission
States Assembly
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
a few seconds ago
- Medscape
Inside Prisons: Europe's New Front Line in Hepatitis Fight
The European Centre for Disease Prevention and Control (ECDC) and the European Union Drugs Agency (EUDA) launched a new toolkit on August 7, 2025, ahead of Prisoners' Justice Day on 10 August. The launch of the European Toolkit for the Elimination of Viral Hepatitis in Prisons (EuroHePP) aims to support local efforts to eliminate viral hepatitis in prison settings in accordance with the United Nations Sustainable Development Goal on Good Health and Well-Being. The EuroHePP provides practical guidance on preventing, evaluating, and treating hepatitis B virus (HBV) and hepatitis C virus (HCV) in prisons. Tackling viral hepatitis in these prison settings is essential to reach the UN target of eliminating hepatitis as a public health threat by 2030. Individuals in prison experience a higher incidence of viral hepatitis than the general population, making them a key group for targeted prevention and treatment of the disease. In Europe, individuals entering prisons are also more likely to have a history of injecting drug use, a major risk factor for HBV and HCV transmission. Sharing of injecting equipment and other risk factors, such as unsafe tattooing or body piercing practices, sharing of razors, and unprotected sex, make prisons a priority setting for targeted viral hepatitis prevention and treatment interventions. The toolkit was developed in collaboration with European experts and practitioners. The toolkit comprises four key sections: background, strategy development, strategy implementation, and monitoring and evaluation. It includes links to relevant public health guidance and practical tools to understand the context and define and implement an elimination strategy in prisons. Examples from prisons in Germany, Spain, France, Italy, and Luxembourg are provided to illustrate the models of care. Using this toolkit, the EUDA and ECDC provide practical, evidence-based information for those working in prison healthcare on how to establish interventions to prevent and control viral hepatitis in these settings. The information is also likely to be relevant to other audiences, including policymakers, security staff, people living in prisons, peer support workers, and voluntary workers. Further support for people working in prison healthcare will be available in the form of dedicated training sessions provided by the EUDA and ECDC in the coming months to facilitate the effective implementation of the toolkit and scaling up of services. Addressing Inequity The project highlights the principle of equivalence of care recognised in European and international law, which states that individuals in prison should receive the same healthcare as those in the community. As the ECDC stated: 'People deprived of their liberty must not also be deprived of their right to health.' A dossier titled Invisible Populations in Epidemiologia & Prevenzione , the journal of the Italian Association of Epidemiology, shows that infectious diseases remain a leading cause of preventable death in prisons. This research, led by Erica De Vita, MD, a resident in Hygiene and Preventive Medicine at the University of Pisa, Pisa, Italy, highlights how prison conditions, such as overcrowding, poor sanitation, rapid turnover, and fragile health, make inmates particularly vulnerable. These factors create a high-risk setting for the spread of infections, including hepatitis B, influenza, human papillomavirus, COVID-19, and pneumococcal disease. The article describes the RISE-Vac project, Reaching the hard-to-reach: increasing access and vaccine uptake among prison populations in Europe , coordinated by the University of Pisa. The project ended in November 2024 after working in six countries: Italy, the UK, France, Germany, Cyprus, and Moldova. Key outcomes included the establishment of vaccination clinics in prisons, such as in Milan, combined with awareness campaigns and health empowerment programs. The project also studied vaccine hesitancy among inmates and staff, showing that health literacy is crucial for improving vaccine acceptance and vaccination coverage. Public Health Impact The scope of the new European 'toolbox' goes beyond the prison walls. Short sentences and repeated incarcerations mean that the same group of people often move between prison and the community. Therefore, addressing health problems, such as viral hepatitis, in prison settings can also deliver health benefits to the wider community by reducing the overall disease burden and preventing future transmission of infections. According to ECDC experts in Stockholm, Sweden, the new toolkit is well-structured, adaptable, and evidence-based. They emphasised the need for political and organisational courage to make it central to public health efforts to fight viral hepatitis in prisons.
Medscape
an hour ago
- Medscape
Phone Support Lowers BMI in Preschool Kids
TOPLINE: A 2-year telephone-based intervention providing nurse-led support calls and short message service (SMS) to mothers was associated with a reduced BMI in children aged up to 5 years, with the greatest benefit seen in those from lower-income families. METHODOLOGY: Telehealth became crucial during the COVID pandemic when face-to-face health programs were suspended; however, evidence on the effectiveness of telephone- and SMS-based obesity interventions for preschool-aged children and their caregivers has been lacking. Researchers conducted an extension study of a clinical trial to evaluate the effectiveness of a 2-year telephone-based intervention in reducing BMI and improving health behaviors among preschool-aged children. Originally, 662 mother-child pairs (children aged 2-3 years) were randomly assigned to receive either a five-stage, telephone-based support program, which included nurse-led calls, SMS, and a mailed booklet on healthy behaviors (intervention group), or mailouts with information unrelated to the intervention (control group). After the first year, the intervention group continued for a second year (when children were 3-4 years old), followed by a 1-year follow-up period (when children were 4-5 years old); the original group allocations were maintained throughout. The primary outcome was child BMI, measured at 3, 4, and 5 years of age. Secondary outcomes included child dietary behaviors, active playtime, screen time, and sleep duration. TAKEAWAY: The intervention group had a significantly lower mean BMI than the control group for children aged 3-5 years (15.90 vs 16.20; mean difference [MD], -0.30; P = .039). The effect of the intervention group was more pronounced among lower-income families (MD, -0.57; P = .018). The intervention group was also associated with greater odds of meeting four or more dietary recommendations (adjusted odds ratio [aOR], 1.70; P = .02), not eating in front of the television (aOR, 2.65; P < .0001), and not eating fast food (aOR, 1.67; P = .047) than the control group for children aged 3-5 years. IN PRACTICE: 'Our study demonstrates the potential for telehealth in a preventive framework to improve obesity risk outcomes of preschool-aged children, particularly low-income children,' the authors wrote. SOURCE: This study was led by Li Ming Wen, Population Health Research & Evaluation Hub, Sydney Local Health District, Camperdown, Australia. It was published online in the International Journal of Obesity. LIMITATIONS: The generalizability of the findings was limited by the study location and participant demographics. Due to the COVID pandemic, the trial intervention and data collection were conducted pragmatically rather than ideally, which may have affected outcomes. Additionally, secondary outcomes were limited by mothers' self-reporting. DISCLOSURES: This study was funded by a National Health and Medical Research Council Partnership grant. The authors declared having no competing interests. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
2 hours ago
- Yahoo
Warren Buffett's Berkshire Hathaway Just Bought Into Beaten-Down UnitedHealth. Should Investors Follow Suit?
Key Points Warren Buffett and a few other high-profile investors bought UnitedHealth stock in Q2. The company has been struggling after it did a poor job of forecasting medical cost trends. However, it should have a clear path to fixing some of the issues it is facing. 10 stocks we like better than UnitedHealth Group › UnitedHealth Group (NYSE: UNH) has run into a very difficult stretch, with the stock price cut nearly in half over the past year. However, a few well-known investors scooped up shares of the stock in the second quarter, including Warren Buffett's Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B). Buffett, through Berkshire, bought more than 5 million shares of the managed care company, worth an estimated $1.6 billion. Meanwhile, Michael Burry, who became famous in the book and movie The Big Short for his bet against subprime mortgages, bought 20,000 shares. Billionaire David Tepper also increased his stake in the name during the quarter. Let's see what these investors see in the struggling health insurance provider. UnitedHealth got caught up in a pricing misstep The biggest issue facing UnitedHealth is the mismatch between how the company priced its health plans and the actual medical costs it is paying out. According to the company, it's expecting to pay out an incredible $6.5 billion more in medical costs than it initially planned for 2025. A big chunk of that -- around $3.6 billion -- is tied to its Medicare plans, which it said are facing a "generational pullback in Medicare funding" that's been in motion for a couple of years. These cost pressures, unfortunately for the company, aren't just hitting one part of its business, though. While Medicare has been the biggest problem, its commercial business has also been under pressure, split evenly between its Affordable Care Act (ACA) and employer businesses. In addition, it's also seeing pressure with Medicaid, particularly when it comes to behavioral health. In its Medicare Advantage segment, UnitedHealth has been seeing care activity, particularly from physician and outpatient services, come in significantly higher than it expected. It initially assumed a Medicare Advantage medical cost trend of just over 5%, but now it expects the actual number to be closer to 7.5% this year. A large part of this appears to be from patients going to the emergency room more frequently, and ERs increasing observational stays and bundling more services as part of these visits. Meanwhile, its OptumHealth division, which is its health service and technology arm, is struggling with its value-based care business. The company said OptumHealth's earnings this year are on track to come in a whopping $6.6 billion below expectations. It said there were three main reasons for this underperformance. The first is its mix in enrollment, as new members who were previously underserved have more complex issues than expected. Second, it's been seeing accelerated medical trends, especially in areas like outpatient procedures and behavioral health. And finally, it underestimated the risk of the new members it added. To try to shift the current tide, UnitedHealth has made significant leadership and operational changes that are focused on improving its clinical and billing systems. The company plans to adjust its pricing strategy for 2026, as it expects that these elevated medical cost trends will continue. The company will also lean into artificial intelligence (AI) to try to increase efficiency, reduce costs, and improve forecasting. Is UnitedHealth stock a buy? While UnitedHealth is going through a rough stretch, the company should be able to turn its business around. The first step is adjusting its pricing to better reflect medical trends when its annual contracts come up for renewal. With the advent of AI, it should be easier now than ever to forecast trends and price accordingly. However, pricing is not the sole fix, and if it sets prices too high, it can also lose members to lower-cost plans. Meanwhile, with Medicare, it can't just increase prices; it must justify any annual price increases as part of its bid to the Centers for Medicare and Medicaid Services (CMS). Meanwhile, CMS will set a benchmark price based on its formula, and then any plans with bids above the benchmark would have to charge a premium to customers above the benchmark price. So while in theory it can increase Medicare pricing, pricing its plan above the benchmark could lead to low enrollment. As such, the company also needs to work on changing patient behavior. Way too many people are using the ER as their primary physician, and hospitals appear to be leaning into this, adding services to increase costs that they then bill to the insurance company. This is a systemic issue impacting the whole U.S. healthcare system, but if UnitedHealth can find a way to incentivize members to use telehealth or urgent care, it could go a long way in helping to keep medical costs down. Repricing some plans should lead to a quick improvement, while changing consumer behavior will take longer. However, I think the worst should be over for UnitedHealth this year. As such, with the stock cut in half and trading at a forward price-to-earnings (P/E) ratio of 16 times 2026 analyst estimates, I think investors can look to follow Buffett and these other well-known investors into the stock. Should you buy stock in UnitedHealth Group right now? Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,466!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,633!* Now, it's worth noting Stock Advisor's total average return is 1,077% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025 Geoffrey Seiler has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy. Warren Buffett's Berkshire Hathaway Just Bought Into Beaten-Down UnitedHealth. Should Investors Follow Suit? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
